105 related articles for article (PubMed ID: 8701638)
1. [The capacity of avirulent forms of Francisella tularensis for dissemination and proliferation in the host body].
Tsimbalistova MV; Pavlovich NV; Sorokin VM; Tynkevich NK
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):10-3. PubMed ID: 8701638
[TBL] [Abstract][Full Text] [Related]
2. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
[TBL] [Abstract][Full Text] [Related]
3. Francisella tularensis resistance to bactericidal action of normal human serum.
Sorokin VM; Pavlovich NV; Prozorova LA
FEMS Immunol Med Microbiol; 1996 Mar; 13(3):249-52. PubMed ID: 8861038
[TBL] [Abstract][Full Text] [Related]
4. [The resistance of Francisella tularensis to the bactericidal action of normal serum as a criterion for evaluating the virulence of the bacterium].
Pavlovich NV; Sorokin VM; Blagorodova NS
Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):7-10. PubMed ID: 8820667
[TBL] [Abstract][Full Text] [Related]
5. [The characterization of Francisella tularensis mutants and subspecies by using monoclonal antibodies].
Aleshkin GI; Efanova EA; Komissarova LV; Kozlovskiĭ VN; Rozhkov EV; Zakharenko VI
Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):18-22. PubMed ID: 9027167
[TBL] [Abstract][Full Text] [Related]
6. [Interaction of S- and R-lipopolysaccharides of Francisella tularensis with lypopolysaccharide-binding protein of human serum].
Onoprienko NN; Pavlovich NV
Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):16-21. PubMed ID: 18819401
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
8. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
[TBL] [Abstract][Full Text] [Related]
9. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J
Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754
[TBL] [Abstract][Full Text] [Related]
11. Virulence of representative Japanese Francisella tularensis and immunologic consequences of infection in mice.
Hotta A; Fujita O; Uda A; Yamamoto Y; Sharma N; Tanabayashi K; Yamada A; Morikawa S
Microbiol Immunol; 2016 Mar; 60(3):168-76. PubMed ID: 26853540
[TBL] [Abstract][Full Text] [Related]
12. Virulence determinants and protective antigens of Francisella tularensis.
Sjöstedt A
Curr Opin Microbiol; 2003 Feb; 6(1):66-71. PubMed ID: 12615222
[TBL] [Abstract][Full Text] [Related]
13. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.
Zarrella TM; Singh A; Bitsaktsis C; Rahman T; Sahay B; Feustel PJ; Gosselin EJ; Sellati TJ; Hazlett KR
PLoS One; 2011; 6(7):e22335. PubMed ID: 21799828
[TBL] [Abstract][Full Text] [Related]
14. Peripheral human γδ T cells control growth of both avirulent and highly virulent strains of Francisella tularensis in vitro.
Rowland CA; Hartley MG; Flick-Smith H; Laws TR; Eyles JE; Oyston PC
Microbes Infect; 2012 Jul; 14(7-8):584-9. PubMed ID: 22370220
[TBL] [Abstract][Full Text] [Related]
15. Virulence comparison in mice of distinct isolates of type A Francisella tularensis.
Twine SM; Shen H; Kelly JF; Chen W; Sjöstedt A; Conlan JW
Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801
[TBL] [Abstract][Full Text] [Related]
16. [The preventive activity of monoclonal antibodies specific to the lipopolysaccharide of Francisella tularensis].
Khlebnikov VS; Vetchinin SS; Grechko GK; Averina AA; Golovlev IR; Averin SF; Zhemchugov VE; Konovalov SI; Anisimov GA; Afanas'ev SS
Zh Mikrobiol Epidemiol Immunobiol; 1992; (9-10):67-70. PubMed ID: 1481610
[TBL] [Abstract][Full Text] [Related]
17. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
Fulop M; Mastroeni P; Green M; Titball RW
Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
[TBL] [Abstract][Full Text] [Related]
18. [The characteristics of the biological properties of capsule-free variants of Francisella tularensis].
Pavlovich NV; Mishan'kin BN; Shimaniuk NIa; Ryzhkova VV; Danilevskaia GI; Mikhalevich RV
Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):21-6. PubMed ID: 8067085
[TBL] [Abstract][Full Text] [Related]
19. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
20. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
Kieffer TL; Cowley S; Nano FE; Elkins KL
Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
